A method for analyzing related substances of terlipressin for injection
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- TIANJIN CHASE SUN PHARM CO LTD
- Publication Date
- 2017-05-24
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicine, and in particular relates to a method for analyzing related substances of terlipressin for injection. Background technique
[0002] The main active ingredient of terlipressin for injection is terlipressin (triglycine-8-lysine-vasopressin), which is a chemically synthesized polypeptide compound. The pharmacological effects of terlipressin are: reduce portal hypertension, reduce blood flow in the portal vein area, contract esophageal smooth muscle, and continuously compress esophageal varices. Terlipressin for injection is mainly used for the treatment of bleeding from esophageal varices.
[0003] Polypeptide compounds are an important class of biologically active molecules. The development of peptide and other biotechnology drug research technologies, such as peptide solid-phase synthesis technology and high-performance liquid chromatography purification and analysis technology, has made the de...